American Claims Evaluation (ALRN)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | HEALTH CARE SERVICES |
| SIC: | SERVICES-SOCIAL SERVICES |
| CEO: | Manuel C. Alves Aivado |
| Employees: | 9 |
| Web site: | aileronrx.com |
|
738 MAIN STREET, UNIT 398, WALTHAM, MA, 02451
617-995-0900
| |
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. Company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma.
Please log in first to see chart